1. Neuroprotective effects of urate are mediated by augmenting astrocytic glutathione synthesis and release
- Author
-
Rachit Bakshi, Hong Zhang, Robert Logan, Ila Joshi, Yuehang Xu, Xiqun Chen, and Michael A. Schwarzschild
- Subjects
Astrocytes ,Glutathione ,Neurons ,Nrf2 ,Urate ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Urate has emerged as a promising target for neuroprotection based on epidemiological observations, preclinical models, and early clinical trial results in multiple neurologic diseases, including Parkinson's disease (PD). This study investigates the astrocytic mechanism of urate's neuroprotective effect. Targeted biochemical screens of conditioned medium from urate- versus vehicle-treated astrocytes identified markedly elevated glutathione (GSH) concentrations as a candidate mediator of urate's astrocyte-dependent neuroprotective effects. Urate treatment also induced the nuclear translocation of the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) protein and transcriptional activation of its key target genes in primary astrocytic cultures. Urate's neuroprotective effect was attenuated when GSH was depleted in the conditioned media either by targeting its synthesis or release by astrocytes. Overall, these results implicate GSH as the extracellular astrocytic factor mediating the protective effect of urate in a cellular model of PD. These results also show that urate can employ a novel indirect neuroprotective mechanism via induction of the Nrf2 signaling pathway, a master regulator of the response to oxidative stress, in astrocytes.
- Published
- 2015
- Full Text
- View/download PDF